| |
| |
| Exchange: |
American Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
135,340,000 |
| Market
Cap: |
621.21(M) |
| Last
Volume: |
11,363,101 |
Avg
Vol: |
11,331,682 |
| 52
Week Range: |
$1.94 - $5.59 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Savara is a clinical stage biopharmaceutical company focused on rare respiratory diseases. Co.'s primary program, molgramostim nebulizer solution is an inhaled biologic, specifically an inhaled granulocyte-macrophage colony-stimulating factor and is being developed for the treatment of autoimmune pulmonary alveolar proteinosis. Molgramostim nebulizer solution is administered once daily by inhalation via a nebulizer, the eFlow® Nebulizer System. The eFlow® Nebulizer System is a reusable electronic inhalation system. Molgramostim was also being investigated in cystic fibrosis (CF) and non-CF patients for the treatment of nontuberculous mycobacterial lung infection, a lung disorder.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
3,439,830 |
4,023,225 |
| Total Buy Value |
$0 |
$0 |
$10,277,564 |
$11,106,809 |
| Total People Bought |
0 |
0 |
12 |
12 |
| Total Buy Transactions |
0 |
0 |
14 |
42 |
| Total Shares Sold |
0 |
187,843 |
187,843 |
187,843 |
| Total Sell Value |
$0 |
$885,322 |
$885,322 |
$885,322 |
| Total People Sold |
0 |
3 |
3 |
3 |
| Total Sell Transactions |
0 |
3 |
3 |
3 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Carlander Carrie |
CFO, Treasurer, VP Finance |
• – – |
2005-05-16 |
4 |
AB |
$2.45 |
$12,250 |
D/D |
5,000 |
15,000 |
|
- |
|
| Carlander Carrie |
CFO, Treasurer, VP Finance |
• – – |
2005-05-02 |
4 |
AB |
$2.45 |
$12,250 |
D/D |
5,000 |
10,000 |
|
- |
|
| Carlander Carrie |
CFO, Treasurer, VP Finance |
• – – |
2005-04-15 |
4 |
AB |
$2.38 |
$11,900 |
D/D |
5,000 |
5,000 |
|
- |
|
| Pykett Mark Jerome |
Director |
– • – |
2005-04-06 |
4 |
B |
$1.69 |
$5,094 |
D/D |
3,000 |
3,000 |
2.39 |
- |
|
| Levine Evan |
CEO & President |
• • – |
2005-03-22 |
4 |
S |
$1.50 |
$4,500 |
D/D |
(3,000) |
4,385,000 |
|
- |
|
| Levine Evan |
CEO & President |
• • – |
2004-11-30 |
4 |
B |
$0.86 |
$1,548 |
D/D |
1,800 |
4,388,000 |
2.73 |
- |
|
| Levine Evan |
CEO & President |
• • – |
2004-10-26 |
4 |
B |
$0.93 |
$2,976 |
D/D |
3,200 |
4,386,200 |
2.73 |
- |
|
| Habita Cellia |
Senior VP, Clinical & Medical |
• – – |
2004-10-07 |
4 |
B |
$1.10 |
$5,500 |
D/D |
5,000 |
5,000 |
2.74 |
- |
|
| Levine Evan |
CEO & President |
• • – |
2004-10-04 |
4 |
B |
$1.19 |
$3,570 |
D/D |
3,000 |
4,383,000 |
2.73 |
- |
|
| Pykett Mark Jerome |
Director |
– • – |
2004-05-24 |
4 |
B |
$2.08 |
$1,040 |
D/D |
500 |
8,000 |
2.31 |
- |
|
| Pykett Mark Jerome |
Director |
– • – |
2004-01-29 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
4,500 |
|
- |
|
| Goldberg Michael M |
Director |
– • – |
2004-01-28 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
20,000 |
|
- |
|
| Virca Nicholas J |
CEO and President |
• • – |
2003-12-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,698 |
347,956 |
|
- |
|
| Robbins Joan M |
Chief Technical Officer |
• – – |
2003-05-28 |
4 |
A |
$0.40 |
$50,000 |
I/I |
125,000 |
125,000 |
|
- |
|
239 Records found
|
|
Page 10 of 10 |
|
|
0.07 (1.4%) 
